Results 151 to 160 of about 12,492 (212)

Performance difference of enrofloxacin monoclonal antibody and nanobody elicited from the same immunogen and the underlying molecular mechanism. [PDF]

Food Chem (Oxf)
Chen Y, Wang Z, He Q, Xing H, Shen S, Feng R, Wu Y, Wang B, Li QX.   +8 more
europepmc   +1 more source

Enhancing the sensitivity of nanobodies through covalent and non-covalent polymerization. [PDF]

RSC Adv
Wang F, Chen J, Chen JH, Liu XM, Hu LQ, Huo LJ.   +5 more
europepmc   +1 more source

A Dually Nanobody-Engineered Milk-Derived Extracellular Vesicle Nanomedicine Targeting Tumour-Associated Macrophages and Cancer Cells for Cancer Therapy. [PDF]

J Extracell Vesicles
Liu Z, Chen Y, Cao Y, Zhang Y, Wang Y, Cheng H, Tang J, Hong H, Feng Y, Yao S, Bian Z, Yin Y, Cui K, Wu Z, Huang Z.   +14 more
europepmc   +1 more source

Regulated proteolysis of green fluorescent protein fusion proteins in Aspergillus fumigatus. [PDF]

G3 (Bethesda)
Paul S, Moye-Rowley WS.
europepmc   +1 more source

Discovery and mechanism of negative allosteric modulation of the α7 nicotinic acetylcholine receptor by nanobodies. [PDF]

Proc Natl Acad Sci U S A
Barilone N, Vangelatou M, Marouf FZ, Dejean de la Bâtie G, Li Q, Lafaye P, Aymé G, Corringer PJ, Prevost MS.   +8 more
europepmc   +1 more source

Crystal structure of Schistosoma mansoni cathepsin D1 in complex with a nanobody reveals the conformation of the propeptide-bound state. [PDF]

Acta Crystallogr D Struct Biol
Parker KL, Clarke JD, Liu X, Gomes BF, Eyssen LEA, Furnham N, Paes Silva-Jr F, Owens RJ.   +7 more
europepmc   +1 more source

Nanobody-Engineered CLL-1 CAR T Cells: Optimizing Tumor-Specific Cytotoxicity and Minimizing Off-Tumor Toxicity. [PDF]

Cancer Res Commun
Tripathi C, Zolov S, Nguyen J, Luh F, Natarajan V, Yen Y.   +5 more
europepmc   +1 more source

HSP-1-specific nanobodies alter chaperone function in vitro and in vivo. [PDF]

J Biol Chem
Urban ND, Gharat K, Mattiola ZJ, Scheutzow A, Klaiss A, Tabler S, Huffaker AW, Grootveld M, Skinner ME, Zheng W, O'Meara MJ, Kirstein J, Truttmann MC.   +12 more
europepmc   +1 more source

Crystal structure and nanobodies against domain 3 of the malaria parasite fusogen Plasmodium falciparum HAP2. [PDF]

Biochem J
Lyons FMT, Chmielewski J, Chan LJ, Gabriela M, Chan RWB, Adair A, Tong J, Pymm P, Zeglinski K, Gouil Q, Tham WH, Dietrich MH.   +11 more
europepmc   +1 more source

A Precision-Engineered DC-Targeting mRNA-LNP Neoantigen Vaccine Elicits Stronger T Cell Responses and Exhibits Superior Tumor Control. [PDF]

Vaccines (Basel)
Liu Q, Liu Y, Li J, Huang S, Chen Z, Li J, Wang T, Zhou P, Huo J, Li D.   +9 more
europepmc   +1 more source